BioMimetic Amends Augment Bone Graft PMA, Expects Approval By 2014
This article was originally published in The Gray Sheet
Executive Summary
BioMimetic Therapeutics submits PMA amendment for its Augment bone graft device to address questions raised by FDA in a “not approvable” letter disclosed in January.